Janet Napolitano

October 17, 2026

Fortinet Expands Cloud Security Framework Amid Sector Pullback. Fortinet announced an expansion of its global cybersecurity framework for hybrid and multi-cloud environments. This product update comes as cybersecurity stocks generally retreat from recent record highs due to market volatility. Mizuho recently raised its price target for the stock to $160 while maintaining an Underperform rating, reflecting mixed views on its valuation.

October 14, 2026

Vir Biotechnology Secures $1.875B Gilead Deal for Cancer Drug Candidates. Vir Biotechnology entered a $1.875 billion partnership with Gilead that includes an upfront cash payment and shares, plus up to $1.785 billion in milestone payments and royalties. The collaboration also covers three PRO‑XTEN dual‑masked T‑cell engager candidates for solid tumors, with one, VIR‑5500, receiving FDA Fast‑Track status for metastatic castration‑resistant prostate cancer. These developments expand Vir’s oncology pipeline and strengthen its relationship with a major biopharma partner.

October 17, 2026

Zoom Stock: Analysts Note AI Growth Potential Amid Market Dip. Recent commentary highlights Zoom's high cash yield and potential for AI-driven growth, though some analysts remain cautious. The stock has recently dipped more than the broader market, trading near its 52-week low. With a low P/E ratio of 7.8, the company is seen as a cash-heavy name, but investors are watching for signs of a turnaround.